Zeo ScientifiX, Inc.
ZEOX
$2.70
$0.000.00%
| Weiss Ratings | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Weak | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.33 | |||
| Price History | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 10.20% | |||
| 30-Day Total Return | 1.89% | |||
| 60-Day Total Return | -19.16% | |||
| 90-Day Total Return | 58.82% | |||
| Year to Date Total Return | -16.41% | |||
| 1-Year Total Return | 57.89% | |||
| 2-Year Total Return | 14.41% | |||
| 3-Year Total Return | -37.79% | |||
| 5-Year Total Return | -44.21% | |||
| 52-Week High % Change | -42.92% | |||
| 52-Week Low % Change | 237.50% | |||
| Price | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.73 | |||
| 52-Week Low Price | $0.80 | |||
| 52-Week Low Price (Date) | May 23, 2024 | |||
| 52-Week High Price (Date) | Nov 22, 2024 | |||
| Valuation | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 17.13M | |||
| Enterprise Value | 17.17M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.75 | |||
| Earnings Per Share Growth | -24.04% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.85 | |||
| Price/Book (Q) | -10.36 | |||
| Enterprise Value/Revenue (TTM) | 3.72 | |||
| Price | $2.70 | |||
| Enterprise Value/EBITDA (TTM) | -3.27 | |||
| Enterprise Value/EBIT | -3.23 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 6.58M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 888 963 7881 | |||
| Address | 3321 College Avenue Davie, FL 33314 | |||
| Website | www.zeoscientifix.com | |||
| Country | United States | |||
| Year Founded | 2011 | |||
| Profitability | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -115.06% | |||
| Profit Margin | -101.83% | |||
| Management Effectiveness | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -150.17% | |||
| Return on Equity | -- | |||
| Income Statement | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.62M | |||
| Total Revenue (TTM) | 4.62M | |||
| Revenue Per Share | $0.70 | |||
| Gross Profit (TTM) | 3.78M | |||
| EBITDA (TTM) | -5.24M | |||
| EBIT (TTM) | -5.32M | |||
| Net Income (TTM) | -4.71M | |||
| Net Income Avl. to Common (TTM) | -4.71M | |||
| Total Revenue Growth (Q YOY) | -12.52% | |||
| Earnings Growth (Q YOY) | -14.94% | |||
| EPS Diluted (TTM) | -0.75 | |||
| EPS Diluted Growth (Q YOY) | -22.82% | |||
| Balance Sheet | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 657.00K | |||
| Cash Per Share (Q) | $0.10 | |||
| Total Current Assets (Q) | 1.17M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -1.65M | |||
| Current Ratio (Q) | 0.354 | |||
| Book Value Per Share (Q) | -$0.26 | |||
| Total Assets (Q) | 1.64M | |||
| Total Current Liabilities (Q) | 3.29M | |||
| Total Debt (Q) | 693.00K | |||
| Total Liabilities (Q) | 3.30M | |||
| Total Common Equity (Q) | -1.65M | |||
| Cash Flow | ZEOX - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -45.00K | |||
| Cash from Financing (TTM) | 396.00K | |||
| Net Change in Cash (TTM) | -1.10M | |||
| Levered Free Cash Flow (TTM) | -953.20K | |||
| Cash from Operations (TTM) | -1.45M | |||
